Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy

Diabetic Medicine

Volumn 22, Issue 10, 2005, Pages 1394-1400

  Yasuda, Gen ^a   Hasegawa, K ^a   Kuji, T ^a   Ogawa, N ^b   Shimura, G ^c   Umemura, S ^a   Tochikubo, O ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOSUKA KYOSAI HOSPITAL   (Japan)

^c Fujisawa City Hospital   (Japan)

Author keywords

1 adrenergic antagonists; Ambulatory blood pressure monitoring; Diabetic nephropathy; Essential hypertension; Power spectral analysis

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; SIDE EFFECT; SLEEP; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DOXAZOSIN; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SLEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 25844472260     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01636.x     Document Type: Article

References (22)

1. Lurbe A, Redón J, Pascual JM, Tacons J, Alvarez V, Batlle DC. Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 1993; 21: 227-235.
2. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995; 44: 783-789.
3. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Gatteschi C et al. Ambulatory blood pressure and risk of cardiovascular disease in type II diabetes mellitus. Diab Nutr Metab 1994; 7: 223-231.
4. Page SR, Manning G, Ingle AR, Hill P, Millar-Craig MW, Peacock I. Raised ambulatory blood pressure in type 1 diabetes with incipient microalbuminuria. Diabet Med 1994; 11: 877-882.
5. van Ittersum FJ, Spek JJ, Praet IJA, Lambert J, IJzerman RG, Fischer HRA et al. Ambulatory blood pressures and autonomic nervous function in normoalbuminuric type I diabetic patients. Nephrol Dial Transplant 1998; 13: 326-332.
6. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects. Hypertension 1995; 26: 808-814.
7. Kario K, Motai K, Mitsuhashi T, Suzuki T, Nakagawa Y, Ikeda U et al. Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation. Hypertension 1997; 30: 1504-1510.
8. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997; 15:205-211.
9. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens 2003; 16: 46-50.
10. Takata Y, Yoshizumi T, Ito Y, Hirota Y, Fujishima M. Effect of administration and withdrawal of doxazosin on ambulatory blood pressure in patients with essential hypertension. Angiology 1995; 46: 11-18.
11. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of α-adrenergic blocker, doxazosin. Hypertension 2000; 35: 787-794.
12. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324.
13. Akaike H. Power spectrum estimation through autoregressive model fitting. Ann Inst Stat Math 1969; 21: 407-419.
14. Akaike H. Fitting autoregressive models for prediction. Ann Inst Stat Math 1969; 21: 243-247.
15. Andersen M. On the calculation of filter coefficients for maximum entropy analysis. Geophysics 1974; 39: 69-72.
16. Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990; 81: 537-547.
17. Tuck ML, Stern N, Sowers JR. Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure. Am J Cardiol 1985; 55: 112-115.
18. Kawano Y, Tochikubo O, Watanabe Y, Miyajima E, Ishii M. Doxazosin suppresses the morning increase in blood pressure and sympathetic nervous activity in patients with essential hypertension. Hypertens Res 1997; 20: 149-156.
19. 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 1995; 18: 125-130.
20. Weinrauch LA, Kennedy FP, Gleason RE, Keough J, D'Elia JA. Relationship between autonomic function and progression of renal disease in diabetic proteinuria. Am J Hypertens 1998; 11: 302-308.
21. Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Human Hypertens 2001; 15: 239-246.
22. Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura U, Tochikubo O. Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Am J Hypertens 2004; 17: 14-20.